La Jolla Pharmaceutical CEO George Tidmarsh's 2018 pay falls 77% to $1.5M
La Jolla Pharmaceutical reports 2018 executive compensation
By ExecPay News
Published: September 18, 2019
La Jolla Pharmaceutical reported fiscal year 2018 executive compensation information on September 18, 2019.
In 2018, four executives at La Jolla Pharmaceutical received on average a compensation package of $948K, a 68% decrease compared to previous year.
Average pay of disclosed executives at La Jolla Pharmaceutical
George F. Tidmarsh, Chief Executive Officer, received $1.5M in total, which decreased by 77% compared to 2017. 55% of Tidmarsh's compensation, or $833K, was in option awards. Tidmarsh also received $75K in non-equity incentive plan, $589K in salary, as well as $12K in other compensation.
Jennifer A. Carver, Chief Operating Officer, received a compensation package of $787K, which decreased by 62% compared to previous year. 51% of the compensation package, or $405K, was in salary.
Lakhmir S. Chawla, Chief Medical Officer, earned $782K in 2018, a 64% decrease compared to previous year.
Dennis M. Mulroy, Chief Financial Officer, received $712K in 2018, which decreases by 65% compared to 2017.
Related executives
You may also like
Source: SEC filing on September 18, 2019.